Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study
Purpose With better access to early diagnosis and appropriate treatment, cervical cancer (CC) burden decreased in several European countries. In Eastern European (EE) countries, which accessed European Union in 2004, CC survival was worse than in the rest of Europe. The present study investigates CC...
Gespeichert in:
| Veröffentlicht in: | Archives of gynecology and obstetrics 2020-02, Vol.301 (2), p.591-602 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 602 |
|---|---|
| container_issue | 2 |
| container_start_page | 591 |
| container_title | Archives of gynecology and obstetrics |
| container_volume | 301 |
| creator | Bielska-Lasota, Magdalena Rossi, Silvia Krzyżak, Michalina Haelens, Annemie Domenic, Augius De Angelis, Roberta Maciejczyk, Adam Rodríguez-Barranco, Miguel Zadnik, Vesna Minicozzi, Pamela |
| description | Purpose
With better access to early diagnosis and appropriate treatment, cervical cancer (CC) burden decreased in several European countries. In Eastern European (EE) countries, which accessed European Union in 2004, CC survival was worse than in the rest of Europe. The present study investigates CC survival differences across five European regions, considering stage at diagnosis (local, regional and metastatic), morphology (mainly squamous versus glandular tumours) and patients’ age.
Methods
We analysed 101,714 CC women diagnosed in 2000–2007 and followed-up to December 2008. Age-standardised 5-year relative survival (RS) and the excess risks of cancer death in the 5 years after diagnosis were computed.
Results
EE women were older and less commonly diagnosed with glandular tumours. Proportions of local stage cancers were similar across Europe, while morphology- and stage-specific RS (especially for non-metastatic disease) were lower in Eastern Europe. Adjusting for age and morphology, excess risk of local stage CC death for EE patients remained higher than that for other European women.
Conclusion
Stage, age and morphology alone do not explain worse survival in Eastern Europe: less effective care may play a role, probably partly due to fewer or inadequate resources being allocated to health care in this area, compared to the rest of Europe. |
| doi_str_mv | 10.1007/s00404-019-05412-5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04076093v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2328757044</sourcerecordid><originalsourceid>FETCH-LOGICAL-c453t-4d21ee9afa6ccd40e67c60ebf9d7b84d0a141ee78f426733ac2e8ffd6e503f7f3</originalsourceid><addsrcrecordid>eNp9kU9vEzEQxS0EomnhC3BAlrjAYWH8b73LLYpCixSpUkTOluMdw1YbO9jZVP32eNlSJA6cPM_-zbM9j5A3DD4yAP0pA0iQFbC2AiUZr9QzsmBS8Ao0Y8_JAtqphlpfkMuc7wAYb5r6JbkQrFFCM74gfos2x5Cpj4kO8Z46TOfe2YE6G0pN81j0ueg-0ID31DqHOfcx0PWY4hFtoLswSRfHcEo95s_U0vVue7tabteVovk0dg-vyAtvh4yvH9crsvuy_ra6qTa3119Xy03lpBKnSnacIbbW29q5TgLW2tWAe992et_IDiyTBdCNl7zWQljHsfG-q1GB8NqLK_Jh9v1hB3NM_cGmBxNtb26WGzPtlYnpuszlzAr7fmaPKf4cMZ_Moc8Oh8EGjGM2XPBGKw1SFvTdP-hdHFMoPymUaploWj1RfKZcijkn9E8vYGCmxMycmCmJmd-JGVWa3j5aj_sDdk8tfyIqgJiBXI7Cd0x_7_6P7S-xnp_P</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2359138974</pqid></control><display><type>article</type><title>Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Bielska-Lasota, Magdalena ; Rossi, Silvia ; Krzyżak, Michalina ; Haelens, Annemie ; Domenic, Augius ; De Angelis, Roberta ; Maciejczyk, Adam ; Rodríguez-Barranco, Miguel ; Zadnik, Vesna ; Minicozzi, Pamela</creator><creatorcontrib>Bielska-Lasota, Magdalena ; Rossi, Silvia ; Krzyżak, Michalina ; Haelens, Annemie ; Domenic, Augius ; De Angelis, Roberta ; Maciejczyk, Adam ; Rodríguez-Barranco, Miguel ; Zadnik, Vesna ; Minicozzi, Pamela ; EUROCARE-5 Working Group ; EUROCARE-5 Working Group</creatorcontrib><description>Purpose
With better access to early diagnosis and appropriate treatment, cervical cancer (CC) burden decreased in several European countries. In Eastern European (EE) countries, which accessed European Union in 2004, CC survival was worse than in the rest of Europe. The present study investigates CC survival differences across five European regions, considering stage at diagnosis (local, regional and metastatic), morphology (mainly squamous versus glandular tumours) and patients’ age.
Methods
We analysed 101,714 CC women diagnosed in 2000–2007 and followed-up to December 2008. Age-standardised 5-year relative survival (RS) and the excess risks of cancer death in the 5 years after diagnosis were computed.
Results
EE women were older and less commonly diagnosed with glandular tumours. Proportions of local stage cancers were similar across Europe, while morphology- and stage-specific RS (especially for non-metastatic disease) were lower in Eastern Europe. Adjusting for age and morphology, excess risk of local stage CC death for EE patients remained higher than that for other European women.
Conclusion
Stage, age and morphology alone do not explain worse survival in Eastern Europe: less effective care may play a role, probably partly due to fewer or inadequate resources being allocated to health care in this area, compared to the rest of Europe.</description><identifier>ISSN: 0932-0067</identifier><identifier>ISSN: 1432-0711</identifier><identifier>EISSN: 1432-0711</identifier><identifier>DOI: 10.1007/s00404-019-05412-5</identifier><identifier>PMID: 31853712</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adolescent ; Adult ; Age ; Aged ; Aged, 80 and over ; Cancer ; Cervical cancer ; Endocrinology ; European Union ; Female ; Gynecologic Oncology ; Gynecology ; Human Genetics ; Humans ; Life Sciences ; Medicine ; Medicine & Public Health ; Metastasis ; Middle Aged ; Morphology ; Obstetrics/Perinatology/Midwifery ; Population-based studies ; Retrospective Studies ; Survival Rate ; Tumors ; Uterine Cervical Neoplasms - epidemiology ; Uterine Cervical Neoplasms - mortality</subject><ispartof>Archives of gynecology and obstetrics, 2020-02, Vol.301 (2), p.591-602</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019</rights><rights>Archives of Gynecology and Obstetrics is a copyright of Springer, (2019). All Rights Reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c453t-4d21ee9afa6ccd40e67c60ebf9d7b84d0a141ee78f426733ac2e8ffd6e503f7f3</citedby><cites>FETCH-LOGICAL-c453t-4d21ee9afa6ccd40e67c60ebf9d7b84d0a141ee78f426733ac2e8ffd6e503f7f3</cites><orcidid>0000-0002-7273-7947</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00404-019-05412-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00404-019-05412-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31853712$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://ut3-toulouseinp.hal.science/hal-04076093$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Bielska-Lasota, Magdalena</creatorcontrib><creatorcontrib>Rossi, Silvia</creatorcontrib><creatorcontrib>Krzyżak, Michalina</creatorcontrib><creatorcontrib>Haelens, Annemie</creatorcontrib><creatorcontrib>Domenic, Augius</creatorcontrib><creatorcontrib>De Angelis, Roberta</creatorcontrib><creatorcontrib>Maciejczyk, Adam</creatorcontrib><creatorcontrib>Rodríguez-Barranco, Miguel</creatorcontrib><creatorcontrib>Zadnik, Vesna</creatorcontrib><creatorcontrib>Minicozzi, Pamela</creatorcontrib><creatorcontrib>EUROCARE-5 Working Group</creatorcontrib><creatorcontrib>EUROCARE-5 Working Group</creatorcontrib><title>Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study</title><title>Archives of gynecology and obstetrics</title><addtitle>Arch Gynecol Obstet</addtitle><addtitle>Arch Gynecol Obstet</addtitle><description>Purpose
With better access to early diagnosis and appropriate treatment, cervical cancer (CC) burden decreased in several European countries. In Eastern European (EE) countries, which accessed European Union in 2004, CC survival was worse than in the rest of Europe. The present study investigates CC survival differences across five European regions, considering stage at diagnosis (local, regional and metastatic), morphology (mainly squamous versus glandular tumours) and patients’ age.
Methods
We analysed 101,714 CC women diagnosed in 2000–2007 and followed-up to December 2008. Age-standardised 5-year relative survival (RS) and the excess risks of cancer death in the 5 years after diagnosis were computed.
Results
EE women were older and less commonly diagnosed with glandular tumours. Proportions of local stage cancers were similar across Europe, while morphology- and stage-specific RS (especially for non-metastatic disease) were lower in Eastern Europe. Adjusting for age and morphology, excess risk of local stage CC death for EE patients remained higher than that for other European women.
Conclusion
Stage, age and morphology alone do not explain worse survival in Eastern Europe: less effective care may play a role, probably partly due to fewer or inadequate resources being allocated to health care in this area, compared to the rest of Europe.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cancer</subject><subject>Cervical cancer</subject><subject>Endocrinology</subject><subject>European Union</subject><subject>Female</subject><subject>Gynecologic Oncology</subject><subject>Gynecology</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Morphology</subject><subject>Obstetrics/Perinatology/Midwifery</subject><subject>Population-based studies</subject><subject>Retrospective Studies</subject><subject>Survival Rate</subject><subject>Tumors</subject><subject>Uterine Cervical Neoplasms - epidemiology</subject><subject>Uterine Cervical Neoplasms - mortality</subject><issn>0932-0067</issn><issn>1432-0711</issn><issn>1432-0711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kU9vEzEQxS0EomnhC3BAlrjAYWH8b73LLYpCixSpUkTOluMdw1YbO9jZVP32eNlSJA6cPM_-zbM9j5A3DD4yAP0pA0iQFbC2AiUZr9QzsmBS8Ao0Y8_JAtqphlpfkMuc7wAYb5r6JbkQrFFCM74gfos2x5Cpj4kO8Z46TOfe2YE6G0pN81j0ueg-0ID31DqHOfcx0PWY4hFtoLswSRfHcEo95s_U0vVue7tabteVovk0dg-vyAtvh4yvH9crsvuy_ra6qTa3119Xy03lpBKnSnacIbbW29q5TgLW2tWAe992et_IDiyTBdCNl7zWQljHsfG-q1GB8NqLK_Jh9v1hB3NM_cGmBxNtb26WGzPtlYnpuszlzAr7fmaPKf4cMZ_Moc8Oh8EGjGM2XPBGKw1SFvTdP-hdHFMoPymUaploWj1RfKZcijkn9E8vYGCmxMycmCmJmd-JGVWa3j5aj_sDdk8tfyIqgJiBXI7Cd0x_7_6P7S-xnp_P</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Bielska-Lasota, Magdalena</creator><creator>Rossi, Silvia</creator><creator>Krzyżak, Michalina</creator><creator>Haelens, Annemie</creator><creator>Domenic, Augius</creator><creator>De Angelis, Roberta</creator><creator>Maciejczyk, Adam</creator><creator>Rodríguez-Barranco, Miguel</creator><creator>Zadnik, Vesna</creator><creator>Minicozzi, Pamela</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><general>Springer Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-7273-7947</orcidid></search><sort><creationdate>20200201</creationdate><title>Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study</title><author>Bielska-Lasota, Magdalena ; Rossi, Silvia ; Krzyżak, Michalina ; Haelens, Annemie ; Domenic, Augius ; De Angelis, Roberta ; Maciejczyk, Adam ; Rodríguez-Barranco, Miguel ; Zadnik, Vesna ; Minicozzi, Pamela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c453t-4d21ee9afa6ccd40e67c60ebf9d7b84d0a141ee78f426733ac2e8ffd6e503f7f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cancer</topic><topic>Cervical cancer</topic><topic>Endocrinology</topic><topic>European Union</topic><topic>Female</topic><topic>Gynecologic Oncology</topic><topic>Gynecology</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Morphology</topic><topic>Obstetrics/Perinatology/Midwifery</topic><topic>Population-based studies</topic><topic>Retrospective Studies</topic><topic>Survival Rate</topic><topic>Tumors</topic><topic>Uterine Cervical Neoplasms - epidemiology</topic><topic>Uterine Cervical Neoplasms - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bielska-Lasota, Magdalena</creatorcontrib><creatorcontrib>Rossi, Silvia</creatorcontrib><creatorcontrib>Krzyżak, Michalina</creatorcontrib><creatorcontrib>Haelens, Annemie</creatorcontrib><creatorcontrib>Domenic, Augius</creatorcontrib><creatorcontrib>De Angelis, Roberta</creatorcontrib><creatorcontrib>Maciejczyk, Adam</creatorcontrib><creatorcontrib>Rodríguez-Barranco, Miguel</creatorcontrib><creatorcontrib>Zadnik, Vesna</creatorcontrib><creatorcontrib>Minicozzi, Pamela</creatorcontrib><creatorcontrib>EUROCARE-5 Working Group</creatorcontrib><creatorcontrib>EUROCARE-5 Working Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Archives of gynecology and obstetrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bielska-Lasota, Magdalena</au><au>Rossi, Silvia</au><au>Krzyżak, Michalina</au><au>Haelens, Annemie</au><au>Domenic, Augius</au><au>De Angelis, Roberta</au><au>Maciejczyk, Adam</au><au>Rodríguez-Barranco, Miguel</au><au>Zadnik, Vesna</au><au>Minicozzi, Pamela</au><aucorp>EUROCARE-5 Working Group</aucorp><aucorp>EUROCARE-5 Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study</atitle><jtitle>Archives of gynecology and obstetrics</jtitle><stitle>Arch Gynecol Obstet</stitle><addtitle>Arch Gynecol Obstet</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>301</volume><issue>2</issue><spage>591</spage><epage>602</epage><pages>591-602</pages><issn>0932-0067</issn><issn>1432-0711</issn><eissn>1432-0711</eissn><abstract>Purpose
With better access to early diagnosis and appropriate treatment, cervical cancer (CC) burden decreased in several European countries. In Eastern European (EE) countries, which accessed European Union in 2004, CC survival was worse than in the rest of Europe. The present study investigates CC survival differences across five European regions, considering stage at diagnosis (local, regional and metastatic), morphology (mainly squamous versus glandular tumours) and patients’ age.
Methods
We analysed 101,714 CC women diagnosed in 2000–2007 and followed-up to December 2008. Age-standardised 5-year relative survival (RS) and the excess risks of cancer death in the 5 years after diagnosis were computed.
Results
EE women were older and less commonly diagnosed with glandular tumours. Proportions of local stage cancers were similar across Europe, while morphology- and stage-specific RS (especially for non-metastatic disease) were lower in Eastern Europe. Adjusting for age and morphology, excess risk of local stage CC death for EE patients remained higher than that for other European women.
Conclusion
Stage, age and morphology alone do not explain worse survival in Eastern Europe: less effective care may play a role, probably partly due to fewer or inadequate resources being allocated to health care in this area, compared to the rest of Europe.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>31853712</pmid><doi>10.1007/s00404-019-05412-5</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-7273-7947</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0932-0067 |
| ispartof | Archives of gynecology and obstetrics, 2020-02, Vol.301 (2), p.591-602 |
| issn | 0932-0067 1432-0711 1432-0711 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_04076093v1 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Adolescent Adult Age Aged Aged, 80 and over Cancer Cervical cancer Endocrinology European Union Female Gynecologic Oncology Gynecology Human Genetics Humans Life Sciences Medicine Medicine & Public Health Metastasis Middle Aged Morphology Obstetrics/Perinatology/Midwifery Population-based studies Retrospective Studies Survival Rate Tumors Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - mortality |
| title | Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A15%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reasons%20for%20low%20cervical%20cancer%20survival%20in%20new%20accession%20European%20Union%20countries:%20a%20EUROCARE-5%20study&rft.jtitle=Archives%20of%20gynecology%20and%20obstetrics&rft.au=Bielska-Lasota,%20Magdalena&rft.aucorp=EUROCARE-5%20Working%20Group&rft.date=2020-02-01&rft.volume=301&rft.issue=2&rft.spage=591&rft.epage=602&rft.pages=591-602&rft.issn=0932-0067&rft.eissn=1432-0711&rft_id=info:doi/10.1007/s00404-019-05412-5&rft_dat=%3Cproquest_hal_p%3E2328757044%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2359138974&rft_id=info:pmid/31853712&rfr_iscdi=true |